ENCBS360WQQ / in vitro differentiated cells
Summary
- Status
- released
- Term name
- cardiovascular progenitor cell
- Term ID
- CL:0002664
- Summary
- Homo sapiens female embryo cardiovascular progenitor in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 5 days, 10 ng/mL Bone morphogenetic protein 4 for 5 days, 6 ng/mL Activin A for 5 days
- Description
- H7 hESC to cardiomyocyte, endothelial and smooth muscle cell differentiation treatment for 5 days
- Originated from biosample
- ENCBS336AYE
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award PI
- John Stamatoyannopoulos, UW
- Submitted by
- Aditi Narayanan
- Source
- Unknown Source
- Project
- ENCODE
- External resources
- Aliases
- john-stamatoyannopoulos:31hao4
Treatment details
- Treatment
- 5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 5 days
- Type
- protein
- Treatment
- 10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 5 days
- Type
- protein
- Treatment
- 6 ng/mL Activin A (CHEBI:81351) for 5 days
- Type
- chemical
Donor information
- Status
- released
- Accession
- ENCDO221AAA
- Aliases
- encode:donor of H7
- Species
- Homo sapiens
- Life stage
- embryonic
- Sex
- female
- External resources
Documents
differentiation protocol
Description: H7 Mesoderm 5-day Differentiation Protocol
- Submitted by
- John Stamatoyannopoulos
- Lab
- John Stamatoyannopoulos, UW
- Grant
- U54HG004592